These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 13035667)

  • 1. Responses to sympathomimetic amines after dibenamine blockade.
    NICKERSON M; NOMAGUCHI GM
    J Pharmacol Exp Ther; 1953 Mar; 107(3):284-99. PubMed ID: 13035667
    [No Abstract]   [Full Text] [Related]  

  • 2. Fundamental basis of the specificity of pressor and depressor amines in their vascular effects. II. Effects of dibenamine on the hypertensive action of pressor amines.
    HUIDOBRO F; CROXATTO R; MANOSALVA W
    Acta Physiol Lat Am; 1951 Jul; 1(3):187-99. PubMed ID: 14943549
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of a new congener of dibenamine on the actions of sympathomimetic amines.
    CORET IA
    Proc Soc Exp Biol Med; 1948; 68(3):553-8. PubMed ID: 18884285
    [No Abstract]   [Full Text] [Related]  

  • 4. Blockade of responses to epinephrine and norepinephrine by dibenamine congeners.
    NICKERSON M; HENRY JW; NOMAGUCHI GM
    J Pharmacol Exp Ther; 1953 Mar; 107(3):300-9. PubMed ID: 13035668
    [No Abstract]   [Full Text] [Related]  

  • 5. [Mechanism of transient increase of the cardiac output in adrenergic blockade with dibenamine].
    BROD J; FEJFAR Z
    Sb Lek; 1951 Oct; 53(5-6):154-69. PubMed ID: 14876347
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanisms of partial blockade of the stress response in rats by dibenamine analogues.
    SAWYER CH; PARKERSON GR
    Endocrinology; 1953 Mar; 52(3):346-56. PubMed ID: 13033846
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of adrenergic alpha- and beta-receptor blocking drugs on the myocardial lesions induced by sympathomimetic amines.
    Méhes G; Papp G; Rajkovits K
    Acta Physiol Acad Sci Hung; 1967; 32(1):175-84. PubMed ID: 6080429
    [No Abstract]   [Full Text] [Related]  

  • 8. Dibenamine blockade of epinephrine and glucagon hyperkalemias.
    ELLIS S; BECKETT SB; BOUTWELL JH
    Proc Soc Exp Biol Med; 1957 Feb; 94(2):343-5. PubMed ID: 13408252
    [No Abstract]   [Full Text] [Related]  

  • 9. Dibenamine blockade as a method of distinguishing between inotropic actions of epinephrine and digitalis.
    COTTEN MD; WALTON RP
    Proc Soc Exp Biol Med; 1951 Dec; 78(3):810-5. PubMed ID: 14912041
    [No Abstract]   [Full Text] [Related]  

  • 10. Failure of dibenamine to block adrenergic inhibitory responses.
    AGARWAL SL; HARVEY SC
    Arch Int Pharmacodyn Ther; 1955 May; 101(4):476-80. PubMed ID: 13239240
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical applications of adrenergic blockade in vascular diseases with special reference to dibenamine and 688A.
    HAIMOVICI H
    Angiology; 1951 Dec; 2(6):531-54. PubMed ID: 14894859
    [No Abstract]   [Full Text] [Related]  

  • 12. Dibenamine: a clinical and experimental study.
    DELONG SL; SCHEIE HG
    AMA Arch Ophthalmol; 1952 Apr; 47(4):542-3. PubMed ID: 14914273
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative sympatholytic effect of sympatholytin and dibenamine].
    KHAUNINA RA
    Fiziol Zh SSSR Im I M Sechenova; 1952; 38(3):344-9. PubMed ID: 12989214
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of dibenamine on phlebohypertonia caused by hypoxia].
    FOLDI M; SOLTI F
    Magy Belorv Arch (1955); 1957 Aug; 10(4):104-5. PubMed ID: 13503318
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of dibenamine on phlebohypertonia induced by anoxia].
    FOLDI M; SOLTI F
    Acta Med Acad Sci Hung; 1956; 10(1-2):49-53. PubMed ID: 13394118
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pharmacology and clinical trial of the adrenergic and sympatholytic  drug, dibenamine].
    MAZZELLA H; NAVARRO A
    Arch Urug Med Cir Espec; 1949 Aug; 35(2):155-7. PubMed ID: 15407905
    [No Abstract]   [Full Text] [Related]  

  • 17. [Amphotropic effects dibenamine].
    BIRKMAYER W
    Acta Neuroveg (Wien); 1951 Aug; 3(1-2):217-8. PubMed ID: 14932888
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparison of the effectiveness of adrenergic blocking drugs in inhibiting the cardiac actions of sympathomimetic amines.
    COTTEN MD; MORAN NC; STOPP PE
    J Pharmacol Exp Ther; 1957 Oct; 121(2):183-90. PubMed ID: 13481841
    [No Abstract]   [Full Text] [Related]  

  • 19. The physiological disposition and biotransformation of dibenamine and a method for its estimation in biological tissues.
    AXELROD J; ARONOW L; BRODIE BB
    J Pharmacol Exp Ther; 1952 Oct; 106(2):166-79. PubMed ID: 12981639
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of the halogen groups in the pharmacological effects of dibenzyl beta-chlorethylamine (dibenamine) and dibenzyl beta-bromethylamine.
    GYERMEK L
    Acta Physiol Acad Sci Hung; 1952; 3(1):165-73. PubMed ID: 13050441
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.